Enhanced Prosthetic Heart Valve with Integrated Sensors and Advanced Materials

Publication ID: 24-11857411_0006_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Prosthetic Heart Valve with Integrated Sensors and Advanced Materials,” Published Technical Disclosure No. 24-11857411_0006_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857411_0006_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,411.

Summary of the Inventive Concept

This inventive concept discloses a novel prosthetic heart valve with integrated sensors for real-time monitoring of fluid flow and pressure, advanced self-lubricating materials for enhanced durability, and a bio-absorbable outer skirt for improved tissue integration.

Background and Problem Solved

The original prosthetic heart valve patent has limitations in terms of durability, tissue integration, and real-time monitoring. The new inventive concept addresses these limitations by incorporating advanced materials and sensors, enhancing the overall performance and lifespan of the valve.

Detailed Description of the Inventive Concept

The prosthetic heart valve comprises an annular frame with an integrated sensor for monitoring fluid flow and pressure within the valve. The sensor is embedded within the perivalvular sealing means and communicates with an external device for real-time monitoring. The leaflet structure is made of a self-lubricating material, reducing friction and wear, and enhancing the valve's durability. The outer skirt is bio-absorbable, allowing for improved tissue ingrowth and integration with the surrounding anatomy. The valve is deployable via a delivery catheter with a retractable sheath, providing precise control of valve expansion.

Novelty and Inventive Step

The new claims introduce novel features such as integrated sensors, self-lubricating materials, and bio-absorbable outer skirts, which are not present in the original patent. These features provide a significant improvement over the existing prosthetic heart valve design, addressing the limitations of durability, tissue integration, and real-time monitoring.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include varying the type of sensor used, incorporating additional features such as anti-calcification treatments, or using different materials for the leaflet structure and outer skirt. These variations could provide further enhancements to the valve's performance and lifespan.

Potential Commercial Applications and Market

The enhanced prosthetic heart valve has significant commercial potential in the medical device industry, particularly in the areas of cardiovascular disease treatment and replacement therapy. The target market includes hospitals, medical research institutions, and patients requiring prosthetic heart valve implantation.

CPC Classifications

SectionClassGroup
A A61 A61F2/2409
A A61 A61F2/2415
A A61 A61F2/2418
A A61 A61L27/3625
A A61 A61L27/50
A A61 A61L27/56
A A61 A61F2/2427
A A61 A61F2230/0054
A A61 A61F2240/001
A A61 A61F2250/0063
A A61 A61F2250/0069
A A61 A61L2430/20

Field of Art

Cardiovascular medical devices, specifically implantable prosthetic heart valves, requiring advanced knowledge of biomaterials, medical device engineering, sensor integration, and minimally invasive surgical techniques

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with expertise in cardiovascular device design, having advanced degrees in bioengineering or medical device engineering, familiar with materials science, sensor integration, and prosthetic valve technologies

Obviousness Rationale

A PHOSITA would recognize that integrating sensors, advanced materials, and improved deployment mechanisms into existing prosthetic heart valve designs represents a natural progression of technological innovation. The core structural elements of the source patent provide a clear foundation for incremental improvements in monitoring, durability, and tissue integration. These variations represent predictable extensions of known prosthetic valve design principles using standard engineering techniques.

Obvious Combinations & Variations

Source Patent Element
Annular frame with radially collapsible configuration for prosthetic valve
PTD Variation
Adding integrated sensor embedded within perivalvular sealing means for real-time monitoring
Obviousness Reasoning
Sensor integration is a known technique in medical device design, and a PHOSITA would recognize the predictable benefit of adding monitoring capabilities to an existing valve structure
Source Patent Element
Outer skirt made of porcine pericardial tissue
PTD Variation
Implementing bio-absorbable outer skirt to enhance tissue integration
Obviousness Reasoning
Material selection for improved tissue interaction is a standard design optimization approach, with predictable outcomes in medical implant technologies
Source Patent Element
Expandable frame deployable through catheter
PTD Variation
Developing delivery system with retractable sheath for precise valve expansion control
Obviousness Reasoning
Refinement of deployment mechanisms represents a typical engineering approach to improving medical device insertion techniques, using known mechanical design principles
Source Patent Element
Leaflet structure secured within frame
PTD Variation
Incorporating self-lubricating materials to reduce friction and wear in leaflet structure
Obviousness Reasoning
Material performance optimization is a standard engineering approach, with predictable goals of reducing mechanical wear and extending device lifespan
Source Patent Element
Prosthetic valve with pericardial tissue components
PTD Variation
Adding anti-calcification treatment to leaflet structure
Obviousness Reasoning
Preventing material degradation is a known challenge in implantable medical devices, and applying protective treatments represents a standard design solution
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857411 and the disclosed technical variations, a person having ordinary skill in the art would find the claimed innovations obvious and lacking inventive step. The incremental improvements in sensor integration, material selection, and deployment mechanisms represent predictable extensions of existing prosthetic heart valve technologies, thus rendering potential patent claims obvious under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,411
TitlePericardial sealing member for prosthetic heart valve
Assignee(s)EDWARDS LIFESCIENCES CORPORATION